based on the results of our phase ii studies of mitoxantrone , etoposide , and cisplatin in malignant lymphoma , we have conducted a phase iii study of a 4-drug combination of these 3 drugs plus prednisolone in relapsed or refractory lymphoma : out of 14 patients , 3 responded completely and 4 did partially , so far .
C0026259
mitoxantrone
C0024299
lymphoma